119th Congress · introduced in the House · Feb 12, 2025
Combating Illicit Xylazine Act
Official title from Congress.gov
Latest action (Sep 16, 2026): Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 623.
View on Congress.govPolicy area: Crime and Law Enforcement
Congressional Research Service summary, version: Introduced in House (Feb 12, 2025)
Combating Illicit Xylazine Act
This bill regulates xylazine under the Controlled Substances Act (CSA).
Xylazine, also known as tranq, is a nonopioid sedative and pain reliever that is approved for use in animals. Recently, the Drug Enforcement Administration (DEA) has reported an increase in trafficking of fentanyl mixed with xylazine.
This bill adds xylazine, including its salts, isomers, and salts of isomers, to schedule III of the CSA. Schedule III controlled substances, including anabolic steroids, buprenorphine, and ketamine, have less potential for abuse than a schedule I or II substance, have a currently accepted medical use, and have low or moderate risk of dependence if abused.
Under the bill, manufacturing, distributing, or dispensing xylazine, or possessing with intent to manufacture, distribute, or dispense xylazine for illicit use is subject to criminal penalties under the CSA. The bill also requires xylazine transactions to be tracked in the drug reporting system maintained by the DEA.
The bill exempts from registration under the CSA persons and entities that possess xylazine (1) lawfully dispensed by a veterinarian or pharmacy and (2) for an animal or for use in certain animal-control or wildlife programs.
The bill also exempts xylazine manufacturers from the CSA's physical security requirements.
Finally, the bill requires the DEA, in coordination with the Food and Drug Administration, to report on (1) the prevalence and impact of illicit xylazine use in the United States, and (2) updated information on the prevalence and proliferation of xylazine trafficking and misuse in the United States.
Show less of the summaryIncludes amendment, cloture, and procedural votes. Each is labeled with its exact question; only a passage question is a vote to pass the bill.
No recorded roll calls on this bill in coverage.
Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 623.
Motion to reconsider laid on the table Agreed to without objection.
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5671-5672)
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
DEBATE - The House proceeded with forty minutes of debate on H.R. 1266.
Considered under suspension of the rules. (consideration: CR H5671-5673)
Mr. Guthrie moved to suspend the rules and pass the bill, as amended.
Placed on the Union Calendar, Calendar No. 715.
Committee on the Judiciary discharged.
Committee on the Judiciary discharged.
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-816, Part I.
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-816, Part I.
Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 48 - 0.
Committee Consideration and Mark-up Session Held
Committee Consideration and Mark-up Session Held
Forwarded by Subcommittee to Full Committee by Voice Vote.
Congressional oversight · Consumer affairs · Criminal procedure and sentencing · Drug safety, medical device, and laboratory regulation · Drug trafficking and controlled substances · Licensing and registrations · Manufacturing · U.S. Sentencing Commission · Veterinary medicine and animal diseases
LD-2 reports whose issue descriptions explicitly cite this bill (bill type and number validated against Congress.gov records). A citation does not establish the client's position or any contact with a member.
Loading lobbying reportsSubcommittee Consideration and Mark-up Session Held
Referred to the Subcommittee on Health.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Introduced in House
Actions from Congress.gov, newest first.
Coverage: reports for 2025 onward, posted Jan 1, 2025 through Oct 23, 2026.
38 citations; showing the 25 most recently posted.
PEACE OFFICERS RESEARCH ASSOCIATION OF CALIFORNIA · lobbying firm or registrant: STEPTOE LLP
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Alcohol and Drug Abuse
$50,000
Paid to lobbying firm
Combating Illicit Xylazine Act (H.R. 1266 / S. 545); Targeting Online Sales of Fentanyl Act (H.R. 5744); Combating Fentanyl Poisonings Act of 2025 (H.R. 5573); Ending Drug Trafficking in Our Communitie…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN CIVIL LIBERTIES UNION · lobbying firm or registrant: AMERICAN CIVIL LIBERTIES UNION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 19, 2026 · issue area: Civil Rights/Civil Liberties
$950,000
Spent on own lobbying
…ed: Reproductive Rights. H.R. 2853-Combating Organized Retail Crime Act of 2025-Issues Lobbied: Sentencing, Mass Incarceration, Criminal Justice, Surveillance. H.R. 1266-Combating Illicit Xylazine Act-Issues Lobbied: Drug Sentencing, Mass Incarceration, Criminal Justice. H.R. 7247-Prison Libraries Act of 2026-Issues Lobbied: Pr…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
THE SENTENCING PROJECT · lobbying firm or registrant: THE SENTENCING PROJECT
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 19, 2026 · issue area: Law Enforcement/Crime/Criminal Justice
Amount not reported
…ortion Act Oppose S. 3397ECCHO Act Oppose S. 3394SAFE Act Oppose S. 1572Federal Carjacking Enforcement Act Oppose H.R. 5415 /S. 3076Nitazene Control Act Oppose H.R. 1266/S. 545Combating Illicit Xylazine Act Oppose H.R. 7970STOP Nitazenes Act Oppose
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. View filing
SERGEANTS BENEVOLENT ASSOCIATION OF NEW YORK CITY · lobbying firm or registrant: LONGBOW PUBLIC POLICY GROUP, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 16, 2026 · issue area: Law Enforcement/Crime/Criminal Justice
$40,000
Paid to lobbying firm
…llness Through Data Act." H.R. 10269, the "Stop Auto Fraud Act," a bill to amend title 18 to include an offense for motor vehicle collision fraud; entire bill. H.R. 1266, the "Combatting Illicit Xylazine Act," a bill to prohibit certain uses of xylazine; entire bill. S. 545, the "Combatting Illicit Xylazine Act," a bill to proh…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN VETERINARY MEDICAL ASSOCIATION · lobbying firm or registrant: AMERICAN VETERINARY MEDICAL ASSOCIATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 14, 2026 · issue area: Pharmacy
$200,712
Spent on own lobbying
Combating Illicit Xylazine Act (HR1266/S545). Controlled Substances used in veterinary medicine, Controlled Substances Act and regulations as related to veterinary medicine. Issues related to the FD…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL ASSOCIATION OF CRIMINAL DEFENSE LAWYERS (NACDL) · lobbying firm or registrant: NATIONAL ASSOCIATION OF CRIMINAL DEFENSE LAWYERS (NACDL)
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 13, 2026 · issue area: Law Enforcement/Crime/Criminal Justice
$15,000
Spent on own lobbying
Cannabis Administration and Opportunity Act (CAOA) (S. 5022); Cashless Bail Reporting Act (H.R. 5625); Combating Illicit Xylazine Act (S. 545/H.R. 1266); Combating Organized Retail Crime Act (CORCA) (S. 1404/H.R. 2853); Continuing Appropriations / temporary funding extension (H.R. 6500); District of Columbia C…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
DUE PROCESS INSTITUTE · lobbying firm or registrant: DUE PROCESS INSTITUTE
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Aug 13, 2026 · issue area: Law Enforcement/Crime/Criminal Justice
$15,000
Spent on own lobbying
…fined terms or weak mens rea protections or those that result in overly harsh incarcerative penalties) in general; opposing the Combating Illicit Xylazine Act (H.R. 1266 / S.545); supporting the Due Process Continuity of Care Act (H.R.1510 / S.1720); supporting sufficient funding for the implementation of the Federal Prison Ove…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SOUTHEAST GEORGIA HOSPITAL SYSTEM · lobbying firm or registrant: CAROL G HOLLADAY & ASSOCIATES
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Health Issues
$24,000
Paid to lobbying firm
…Act of 2025 (Kelly, DelBene): Reduces variation in prior authorization methods for Medicare Advantage plans American Hospital Association. Illicit Drug Control H.R. 1266 - Combatting Illicit Xylazine Act (Panetta, Pfluger): Places xylazine on the controlled substances list subscriber.politicopro.com. H.R. 7970 - STOP Nitazenes…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN CIVIL LIBERTIES UNION · lobbying firm or registrant: AMERICAN CIVIL LIBERTIES UNION
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Civil Rights/Civil Liberties
$670,000
Spent on own lobbying
…ed: Reproductive Rights. H.R. 2853-Combating Organized Retail Crime Act of 2025-Issues Lobbied: Sentencing, Mass Incarceration, Criminal Justice, Surveillance. H.R. 1266-Combating Illicit Xylazine Act-Issues Lobbied: Drug Sentencing, Mass Incarceration. H.R. 7247-Prison Libraries Act of 2026-Issues Lobbied: Prison Reform. H.R.…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN MEDICAL ASSOCIATION · lobbying firm or registrant: AMERICAN MEDICAL ASSOCIATION
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · amended · posted Jul 20, 2026 · issue area: Alcohol and Drug Abuse
$5,130,000
Spent on own lobbying
H.R.1266 - Combating Illicit Xylazine Act, all provisions H.R.1561 - ALERT Communities Act, all provisions H.R.2004 - Tylers Law, all provisions H.R.7970 - STOP Nitazen…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
THE SENTENCING PROJECT · lobbying firm or registrant: THE SENTENCING PROJECT
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Law Enforcement/Crime/Criminal Justice
$14,111
Spent on own lobbying
…ortion Act Oppose S. 3397ECCHO Act Oppose S. 3394SAFE Act Oppose S. 1572Federal Carjacking Enforcement Act Oppose H.R. 5415 /S. 3076Nitazene Control Act Oppose H.R. 1266/S. 545Combating Illicit Xylazine Act Oppose H.R. 7970STOP Nitazenes Act Oppose
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
PEACE OFFICERS RESEARCH ASSOCIATION OF CALIFORNIA · lobbying firm or registrant: STEPTOE LLP
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 19, 2026 · issue area: Alcohol and Drug Abuse
$50,000
Paid to lobbying firm
Combating Illicit Xylazine Act (H.R. 1266 / S. 545); Targeting Online Sales of Fentanyl Act (H.R. 5744); Combating Fentanyl Poisonings Act of 2025 (H.R. 5573); Ending Drug Trafficking in Our Communitie…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN VETERINARY MEDICAL ASSOCIATION · lobbying firm or registrant: AMERICAN VETERINARY MEDICAL ASSOCIATION
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 17, 2026 · issue area: Pharmacy
$214,422
Spent on own lobbying
Combating Illicit Xylazine Act (HR1266/S545). Controlled Substances used in veterinary medicine, Controlled Substances Act and regulations as related to veterinary medicine. Issues related to the FD…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
DRUG POLICY ALLIANCE · lobbying firm or registrant: DRUG POLICY ALLIANCE
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 17, 2026 · issue area: Law Enforcement/Crime/Criminal Justice
$18,639
Spent on own lobbying
…urged Congress to support and co-sponsor the Cannabis Administration and Opportunity Act in the Senate. We urged Congress to oppose the Combating Xylazine Act(H.R. 1266/S. 545), Nitazene Control Act (H.R. 5415 /S. 3076), and STOP Nitazenes Act (H.R. 7970).
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL ASSOCIATION OF CRIMINAL DEFENSE LAWYERS (NACDL) · lobbying firm or registrant: NATIONAL ASSOCIATION OF CRIMINAL DEFENSE LAWYERS (NACDL)
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 14, 2026 · issue area: Law Enforcement/Crime/Criminal Justice
$15,000
Spent on own lobbying
Combatting Illicit Xylazine Act (H.R. 1266, S. 545); Federal Carjacking Enforcement Act (H.R. 6155, S. 1572); Make the District of Columbia Safe and Beautiful Act of 2025 (H.R. 5103); Combating Organize…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
DUE PROCESS INSTITUTE · lobbying firm or registrant: DUE PROCESS INSTITUTE
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Jun 1, 2026 · issue area: Law Enforcement/Crime/Criminal Justice
$15,000
Spent on own lobbying
…fined terms or weak mens rea protections or those that result in overly harsh incarcerative penalties) in general; opposing the Combating Illicit Xylazine Act (H.R. 1266 / S.545); supporting the Due Process Continuity of Care Act (H.R.1510 / S.1720); supporting sufficient funding for the implementation of the Federal Prison Ove…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN CIVIL LIBERTIES UNION · lobbying firm or registrant: AMERICAN CIVIL LIBERTIES UNION
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 20, 2026 · issue area: Civil Rights/Civil Liberties
$720,000
Spent on own lobbying
…ody Camera Paywalls Act-Issues Lobbied: Policing Reform. H.R. 2853-Combating Organized Retail Crime Act of 2025-Issues Lobbied: Sentencing, Mass Incarceration. H.R. 1266-Combating Illicit Xylazine Act-Issues Lobbied: Drug Sentencing, Mass Incarceration. H.R. 7247-Prison Libraries Act of 2026-Issues Lobbied: Prison Reform. H.R.…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
THE SENTENCING PROJECT · lobbying firm or registrant: THE SENTENCING PROJECT
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 20, 2026 · issue area: Law Enforcement/Crime/Criminal Justice
$17,342
Spent on own lobbying
…ortion Act Oppose S. 3397ECCHO Act Oppose S. 3394SAFE Act Oppose S. 1572Federal Carjacking Enforcement Act Oppose H.R. 5415 /S. 3076Nitazene Control Act Oppose H.R. 1266/S. 545Combating Illicit Xylazine Act Oppose H.R. 7970STOP Nitazenes Act Oppose
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
DRUG POLICY ALLIANCE · lobbying firm or registrant: DRUG POLICY ALLIANCE
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 19, 2026 · issue area: Law Enforcement/Crime/Criminal Justice
Amount not reported
We urged Congress to support and co-sponsor the MORE Act (H.R. 5068). We urged Congress to oppose the Combating Xylazine Act(H.R. 1266/S. 545), Nitazene Control Act (H.R. 5415 /S. 3076), and STOP Nitazenes Act (H.R. 7970).
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. View filing
PEACE OFFICERS RESEARCH ASSOCIATION OF CALIFORNIA · lobbying firm or registrant: STEPTOE LLP
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 19, 2026 · issue area: Alcohol and Drug Abuse
$50,000
Paid to lobbying firm
Combating Illicit Xylazine Act (H.R. 1266 / S. 545); Targeting Online Sales of Fentanyl Act (H.R. 5744); Combating Fentanyl Poisonings Act of 2025 (H.R. 5573); Ending Drug Trafficking in Our Communitie…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SERGEANTS BENEVOLENT ASSOCIATION OF NEW YORK CITY · lobbying firm or registrant: LONGBOW PUBLIC POLICY GROUP, LLC
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 10, 2026 · issue area: Law Enforcement/Crime/Criminal Justice
$40,000
Paid to lobbying firm
…ficer, judge, prosecutor, or firefighter or other first responder; and enact necessary reforms to the Law Enforcement Officers Safety Act of 2004; entire bill. H.R. 1266, the "Combatting Illicit Xylazine Act," a bill to prohibit certain uses of xylazine; entire bill. S. 545, the "Combatting Illicit Xylazine Act," a bill to proh…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN VETERINARY MEDICAL ASSOCIATION · lobbying firm or registrant: AMERICAN VETERINARY MEDICAL ASSOCIATION
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 9, 2026 · issue area: Pharmacy
$209,147
Spent on own lobbying
Xylazine; Combating Illicit Xylazine Act (HR1266/S545); Controlled Substances used in veterinary medicine, Controlled Substances Act and regulations as related to veterinary medicine. Issues related to the FD…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL ASSOCIATION OF CRIMINAL DEFENSE LAWYERS (NACDL) · lobbying firm or registrant: NATIONAL ASSOCIATION OF CRIMINAL DEFENSE LAWYERS (NACDL)
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 7, 2026 · issue area: Law Enforcement/Crime/Criminal Justice
$15,000
Spent on own lobbying
…a Cash Bail Reform Act (H.R. 5214); Safer Supervision Act (S. 3077); Smarter Pretrial Detention for Drug Charges Act (S. 3960); Combatting Illicit Xylazine Act(H.R. 1266, S. 545); STOP Nitazenes Act (H.R. 7970); FY2027 Commerce, Justice, Science and Related Agencies appropriations bill (mental health funding); Proposed amendmen…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
DUE PROCESS INSTITUTE · lobbying firm or registrant: DUE PROCESS INSTITUTE
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · posted Feb 25, 2026 · issue area: Law Enforcement/Crime/Criminal Justice
$10,000
Spent on own lobbying
…fined terms or weak mens rea protections or those that result in overly harsh incarcerative penalties) in general; opposing the Combating Illicit Xylazine Act (H.R. 1266 / S.545); supporting the Due Process Continuity of Care Act (H.R.1510 / S.1720); supporting sufficient funding for the implementation of the Federal Prison Ove…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
PEACE OFFICERS RESEARCH ASSOCIATION OF CALIFORNIA · lobbying firm or registrant: STEPTOE LLP
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · posted Jan 20, 2026 · issue area: Law Enforcement/Crime/Criminal Justice
$50,000
Paid to lobbying firm
…scher Memorial Interdiction of Fentanyl in Postal Mail at Federal Prisons Act / BOP SCAN Mail Act (S. 1295, H.R. 1046); Combating Illicit Xylazine Act (S. 545, H.R. 1266); Prosecutors Need to Prosecute Act (S. 234, H.R. 350); Combating Organized Retail Crime Act (S. 1404, H.R. 2853); HIRRE Prosecutors Act; Supporting the Health…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing